Table 8 Regression results with healthcare system types: Case fatality rate
From: Health system characteristics and COVID-19 performance in high-income countries
| Â | Model 10a | Model 10b | Model 11a | Model 11b | Model 12a | Model 12b |
|---|---|---|---|---|---|---|
| Â | Î’ (sd) | Î’ (sd) | Î’ (sd) | Î’ (sd) | Î’ (sd) | Î’ (sd) |
(Intercept) | -0.43* | -0.43** | -0.48 | -0.48 | -0.43* | -0.43** |
| Â | (0.21) | (0.13) | (0.45) | (0.26) | (0.21) | (0.12) |
Financing type 3 | 1.20** | 0.61* | Â | Â | Â | Â |
| Â | (0.35) | (0.24) | Â | Â | Â | Â |
Financing type 4 | 0.48 | 0.48* | Â | Â | Â | Â |
| Â | (0.35) | (0.22) | Â | Â | Â | Â |
Provision type 2 | Â | Â | 0.55 | 0.18 | Â | Â |
| Â | Â | Â | (0.59) | (0.36) | Â | Â |
Provision type 4 | Â | Â | 0.28 | 0.28 | Â | Â |
| Â | Â | Â | (0.51) | (0.30) | Â | Â |
Provision type 5 | Â | Â | 0.77 | 0.39 | Â | Â |
| Â | Â | Â | (0.53) | (0.32) | Â | Â |
Combined type 3 | Â | Â | Â | Â | 0.78* | 0.36 |
| Â | Â | Â | Â | Â | (0.36) | (0.21) |
Combined type 4 | Â | Â | Â | Â | 0.73 | 0.50* |
| Â | Â | Â | Â | Â | (0.37) | (0.22) |
Mexico | Â | 4.33*** | Â | 4.60*** | Â | 4.58*** |
| Â | Â | (0.62) | Â | (0.61) | Â | (0.58) |
China | Â | 2.13** | Â | 2.61*** | Â | 2.23*** |
| Â | Â | (0.62) | Â | (0.64) | Â | (0.58) |
N | 41 | 41 | 41 | 41 | 41 | 41 |
R2 | 0.24 | 0.71 | 0.07 | 0.70 | 0.14 | 0.73 |
adj. R2 | 0.2 | 0.67 | -0.01 | 0.65 | 0.10 | 0.70 |
logLik | -52.97 | -33.48 | -56.26 | -33.20 | -54.55 | -30.87 |
AIC | 113.94 | 78.96 | 122.51 | 80.40 | 117.09 | 73.73 |
BIC | 120.79 | 89.24 | 131.08 | 92.39 | 123.95 | 84.02 |